Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines
Renato José da Silva Oliveira(Hospital de Câncer de Barretos), Rui Manuel Reis(University of Minho)
Cited by 10
Related Papers
Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
|PLoS ONE|2012|63
RKIP Inhibition in Cervical Cancer Is Associated with Higher Tumor Aggressive Behavior and Resistance to Cisplatin Therapy
|PLoS ONE|2013|61